Home› India› Ministry of Chemicals and Fertilizers› Extending separate ceiling price of IV Fluids in special pac...
Date: 19-Dec-2024 Category: Extra Ordinary State: Union Government Country: India

Extending separate ceiling price of IV Fluids in special packaging

Issued by Ministry of Chemicals and Fertilizers · Department of Pharmaceuticals

Research with AI Agent Chat with Document Generate Summary Translate Helpful Share Add to Project Create Task

Executive Summary & Key Takeaways

What it means

  • This gazette notification comprises a series of addendums to previous orders issued by the National Pharmaceutical Pricing Authority (NPPA).
  • These addendums relate to the ceiling price fixation of scheduled formulation packs of I.V. fluids (non-glass with special features).
  • The primary change is the inclusion of M/s Jedux Parenteral Private Limited and its product JEDUX DOUBLE PORT WITH EURO HEAD, JPORT PLUS in Table B of various existing orders.
  • Each addendum specifies which formulations from Table A are applicable for M/s Jedux Parenteral Private Limited.

Key Changes

  • S.O. 5499(E) adds Sl. No. 28 to Table B for M/s Jedux Parenteral Private Limited. It specifies that only the prices of formulations listed in Sl. No. 1, 2, 3, 4, 5, 7, and 8 of Table A are applicable to them.
  • S.O. 5500(E) adds Sl. No. 21 to Table B for M/s Jedux Parenteral Private Limited. It specifies that only the prices of formulations listed in Sl. No. 3 and 4 of Table A are applicable to them.
  • S.O. 5501(E) adds Sl. No. 7 to Table B for M/s Jedux Parenteral Private Limited.
  • S.O. 5502(E) adds Sl. No. 2 to Table B for M/s Jedux Parenteral Private Limited.
  • S.O. 5503(E) adds Sl. No. 9 to Table B for M/s Jedux Parenteral Private Limited.
  • S.O. 5504(E) adds Sl. No. 8 to Table B for M/s Jedux Parenteral Private Limited.
  • S.O. 5505(E) adds Sl. No. 2 to Table B for M/s Jedux Parenteral Private Limited.
  • All addendums are in relation to the product 'JEDUX DOUBLE PORT WITH EURO HEAD, JPORT PLUS' manufactured by M/s Jedux Parenteral Private Limited.
  • The addendums are issued under file number 8(128)/2024/D.P./NPPA-Div.-II.

Impact Analysis

Pharmaceutical Manufacturer (M/s Jedux Parenteral Private Limited)

  • Action Item: Review the pricing of JEDUX DOUBLE PORT WITH EURO HEAD, JPORT PLUS in light of the specified formulations in Table A and ensure compliance with the new ceiling prices.

National Pharmaceutical Pricing Authority (NPPA)

  • Action Item: Update internal records and systems to reflect the inclusion of M/s Jedux Parenteral Private Limited and its product in the relevant price control orders. Monitor compliance.

Consumers/Patients

  • Action Item: No specific action is required, but consumers should be aware of the price regulations to ensure they are not overcharged.

Hospitals and Healthcare Providers

  • Action Item: Update procurement systems and billing practices to ensure compliance with the new price regulations.

Key Entities Referenced

National Pharmaceutical Pricing Authority (NPPA): The regulatory body responsible for fixing and controlling the prices of pharmaceutical products in India. M/s Jedux Parenteral Private Limited: A pharmaceutical manufacturer whose product, JEDUX DOUBLE PORT WITH EURO HEAD, JPORT PLUS, is the subject of these addendums. Gazette of India: The official government publication where these notifications are published. Order No. 1552(E) dated 26th March, 2024: Original order related to ceiling price fixation of I.V. fluids (non-Glass with special features). Order No. 2293(E) dated 14th June, 2024: Original order related to ceiling price fixation of I.V. fluids (non-Glass with special features). Order No. 1553(E) dated 26th March, 2024: Original order related to ceiling price fixation of scheduled formulations. Order No. 2292(E) dated 14th June, 2024: Original order related to ceiling price fixation of scheduled formulations. Order No. 1556(E) dated 26th March, 2024: Original order related to ceiling price fixation of scheduled formulations. Order No. 2288(E) dated 14th June, 2024: Original order related to ceiling price fixation of scheduled formulations. Order No. 2286(E) dated 14th June, 2024: Original order related to ceiling price fixation of scheduled formulations. Order No. 1555(E) dated 26th March, 2024: Original order related to ceiling price fixation of scheduled formulations. Order No. 2291(E) dated 14th June, 2024: Original order related to ceiling price fixation of scheduled formulations. Order No. 1557(E) dated 26th March, 2024: Original order related to ceiling price fixation of scheduled formulations. Order No. 2287(E) dated 14th June, 2024: Original order related to ceiling price fixation of scheduled formulations. Order No. 2289(E) dated 14th June, 2024: Original order related to ceiling price fixation of scheduled formulations.
Official Source Record View Original Source →
See Full Document Text
रजिस्ट्री स.ं डी.एल.- 33004/99 REGD. No. D. L.-33004/99 सी.जी.-डी.एल.-अ.-19122024-259538 CG-DxLx-xEG-I1D9H1x2x2x0 24-259538 xxxGIDExxx असाधारण EXTRAORDINARY भाग II—खण् ड 3—उप-खण्ड (ii) PART II—Section 3—Sub-section (ii) प्राजधकार स ेप्रकाजित PUBLISHED BY AUTHORITY स.ं 5090] नई दिल्ली, बहृ स्ट्प जतर्ार, दिसम्ब र 19, 2024/अग्रहायण 28, 1946 No. 5090] NEW DELHI, THURSDAY, DECEMBER 19, 2024/AGRAHAYANA 28, 1946 रसायन और उर्रव क मत्रं ालय (औषध जर्भाग) (राष्ट्रीय औषध मल्ू य जनधारव ण प्राजधकरण) पररजिष्ट नई दिल्ली, 19 दिसम्बर, 2024 का.आ. 5499(अ).—भारत के असाधारण, रािपत्र म ें प्रकाजित, राष्ट्रीय औषध मूल्य जनधावरण प्राजधकरण के आिेि संख्या 1552(अ) दिनांक 26 मार् व 2024 के साथ परित 2293(अ) दिनांक 14 िून 2024, िोदक I.V. तरल पिाथ व (जर्िेष सुजर्धाओं के साथ नॉन-ग्लास) के अनुसूजर्त फॉम्युवलेिन पैक्स के अजधकतम मूल्य जनधावरण स े संबंजधत ह ै को अब स े जनम्नजलजखत िोडकर पढा िाये: (1) क्र. संख्या 28 को ताजलका 'बी' म ें जनम्नानुसार िोडा िाएगा: क्र.स ं जर्जनमातव ाओं का नाम उत्पाि/ब्ाडं का नाम (1) (2) (3) 28. मेससव िेडुक्स परेंटल्स प्राइर्ेट जलजमटेड (नीर्े नोट छ1) िेडुक्स डबल पोटव यूरो हडे कैप के साथ, िपे ोटव प्लस 8210 GI/2024 (1)2 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] (2) खडं (छ1) को खंड (छ) के बाि िोडा गया ह ैऔर इस े इस प्रकार पढा िाएगा: “(छ1) ताजलका बी की क्रमांक संख्या 28 म ें उजल्लजखत मेससव िेडुक्स परेंटल्स प्राइर्ेट जलजमटेड के मामले म,े केर्ल ताजलका ए की क्रमांक संख्या 1,2,3,4,5,7 और 8 म े जनर्िष्टव फॉमूवलेिन की कीमत ेंलाग ू होती ह।ैं [पी.एन./260/128/2024/एफ /फा. स.ं 8(128)/2024/डी.पी./एनपीपीए-डीर्ी-II] महार्ीर सैनी, उप जनिेिक MINISTRY OF CHEMICALS AND FERTILIZERS (Department of Pharmaceuticals) (NATIONAL PHARMACEUTICAL PRICING AUTHORITY) ADDENDUM New Delhi, the 19th December, 2024 S.O. 5499(E).—The National Pharmaceutical Pricing Authority’s Order No. 1552(E) dated 26th March, 2024 read with S.O. 2293(E) dated 14th June 2024, published in the Gazette of India, Extraordinary, related to ceiling price fixation of scheduled formulation packs of I.V. fluids (non-Glass with special features) is henceforth to be read with the following additions: (1) Sl. No. 28 shall be added in Table ‘B’ as below: Sl. No. Name of Manufacturer Product/ Brand Name (1) (2) (3) 28. M/s Jedux Parenteral Private Limited (note g1 below) JEDUX DOUBLE PORT WITH EURO HEAD, JPORT PLUS (2) Clause (g1) is added after clause (g) & shall be read as follows: “(g1) In case of M/s Jedux Parenteral Private Limited mentioned in Sl. No. 28 of Table B, only the prices of the formulations specified in Sl. No. 1,2,3,4,5,7 & 8 of Table A are applicable” [PN/260/128/2024/F /F. No. 8(128)/2024/D.P./NPPA-Div.-II] MAHAVEER SAINI, Dy. Director पररजिष्ट नई दिल्ली, 19 दिसम्बर, 2024 का.आ. 5500(अ).—भारत के असाधारण रािपत्र म ें प्रकाजित राष्ट्रीय औषध मल्ू य जनधारव ण प्राजधकरण के आििे संख्या 1553(अ) दिनांक 26 मार् व 2024 के साथ परित 2292(अ) दिनांक 14 िून 2024, िो उसमें जनर्िवष्ट अनुसूजर्त फॉमूवलेिन के अजधकतम मल्ू य जनधावरण से संबंजधत ह,ै को अब से जनम्नजलजखत िोडकर पढा िाना र्ाजहए: (1) क्र. संख्या 21 को ताजलका 'बी' में जनम्नानुसार िोडा िाएगा: क्र.स ं जर्जनमातव ाओं का नाम उत्पाि/ब्ाडं का नाम (1) (2) (3) 21. मेससव िेडुक्स परेंटल्स प्राइर्ेट जलजमटेड िेडुक्स डबल पोटव यूरो हडे कैप के साथ, िपे ोटव प्लस (2) खडं (ड2) को खंड (ड1) के बाि िोडा गया ह ैऔर इसे इस प्रकार पढा िाएगा:[भाग II—खण् ड 3(ii)] भारत का रािपत्र : असाधारण 3 “(ड2) ताजलका बी की क्रमांक संख्या 21 म ें उजल्लजखत मेससव िेडुक्स परेंटल्स प्राइर्ेट जलजमटेड के मामले म,े केर्ल ताजलका ए की क्रमांक सख्ं या 3 और 4 म ेजनर्िवष्ट फॉमूवलेिन की कीमत ेंलाग ू होती ह।ैं [पी.एन./260/128/2024/एफ /फा. स.ं 8(128)/2024/डी.पी./एनपीपीए-डीर्ी-II] महार्ीर सैनी, उप जनिेिक ADDENDUM New Delhi, the 19th December, 2024 S.O. 5500(E).—The National Pharmaceutical Pricing Authority’s Order No. 1553(E) dated 26th March, 2024 read with S.O. 2292(E) dated 14th June 2024, published in the Gazette of India, Extraordinary, related to ceiling price fixation of scheduled formulations as specified therein is henceforth to be read with the following additions: (1) Sl. No. 21 shall be added in Table ‘B’ as below: Sl. Name of Manufacturer Product/Brand Name No. (1) (2) (3) 21. M/s Jedux Parenteral Private Limited (note e2 JEDUX DOUBLE PORT WITH EURO HEAD, below) JPORT PLUS (2) Clause (e2) is added after clause (e1) & shall be read as follows: “(e2) In case of M/s Jedux Parenteral Private Limited mentioned in Sl. No. 21 of Table B, only the prices of the formulations specified in Sl. No. 3 & 4 of Table A are applicable.” [PN/260/128/2024/F /F. No. 8(128)/2024/D.P./NPPA-Div.-II] MAHAVEER SAINI, Dy. Director पररजिष्ट नई दिल्ली, 19 दिसम्बर, 2024 का.आ. 5501(अ).—भारत के असाधारण रािपत्र म ें प्रकाजित राष्ट्रीय औषध मल्ू य जनधारव ण प्राजधकरण के आििे संख्या 1556(अ) दिनांक 26 मार् व 2024 के साथ परित 2288 (अ) दिनांक 14 िून 2024 , िो उसमें जनर्िष्टव अनुसूजर्त फॉमूवलेिन के अजधकतम मल्ू य जनधावरण से संबंजधत ह,ै को अब से जनम्नजलजखत िोडकर पढा िाना र्ाजहए: (1) क्र. संख्या 7 को ताजलका 'बी' में जनम्नानुसार िोडा िाएगा: क्र.स ं जर्जनमातव ाओं का नाम उत्पाि/ब्ाडं का नाम (1) (2) (3) 7. मेससव िेडुक्स परेंटल्स प्राइर्ेट जलजमटेड िेडुक्स डबल पोटव यूरो हडे कैप के साथ, िपे ोटव प्लस [पी.एन./260/128/2024/एफ /फा. स.ं 8(128)/2024/डी.पी./एनपीपीए-डीर्ी-II] महार्ीर सैनी, उप जनिेिक ADDENDUM New Delhi, the 19th December, 2024 S.O. 5501(E).—The National Pharmaceutical Pricing Authority’s Order No. 1556(E) dated 26th March 2024 read with S.O. 2288(E) dated 14th June 2024, published in the Gazette of India, Extraordinary, related to ceiling price fixation of the scheduled formulation as specified therein is henceforth to be read with the following additions:4 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] (1) Sl. No. 7 shall be added in Table ‘B’ as below: Sl. No. Name of Manufacturer Product /Brand Name (1) (2) (3) 7. M/s Jedux Parenteral Private Limited JEDUX DOUBLE PORT WITH EURO HEAD, JPORT PLUS [PN/260/128/2024/F /F. No. 8(128)/2024/D.P./NPPA-Div.-II] MAHAVEER SAINI, Dy. Director पररजिष्ट नई दिल्ली, 19 दिसम्बर, 2024 का.आ. 5502(अ).—भारत के असाधारण रािपत्र म ें प्रकाजित राष्ट्रीय औषध मल्ू य जनधारव ण प्राजधकरण के आििे संख्या 2286(अ) दिनांक 14 िनू 2024 िो उसम ें जनर्िवष्ट अनसु ूजर्त फॉमूवलेिन के अजधकतम मल्ू य जनधावरण से संबंजधत ह,ै प्राजधकरण की 128र्ीं बैिक में जलये गये जनणवय के अनुसरण में, को अब स ेजनम्नजलजखत िोडकर पढा िाना र्ाजहए: (1) क्र. संख्या 2 को ताजलका 'बी' में जनम्नानुसार िोडा िाएगा: क्र.स ं जर्जनमातव ाओं का नाम उत्पाि/ब्ाडं का नाम (1) (2) (3) 2. मेससव िेडुक्स परेंटल्स प्राइर्ेट जलजमटेड िेडुक्स डबल पोटव यूरो हडे कैप के साथ, िपे ोटव प्लस [पी.एन./260/128/2024/एफ /फा. स.ं 8(128)/2024/डी.पी./एनपीपीए-डीर्ी-II] महार्ीर सैनी, उप जनिेिक ADDENDUM New Delhi, the 19th December, 2024 S.O. 5502(E).—The National Pharmaceutical Pricing Authority’s Order No 2286(E) dated 14th June 2024, published in the Gazette of India, Extraordinary, related to ceiling price fixation of scheduled formulation as specified therein, in pursuance to the decision taken in 128th meeting of the Authority, is henceforth to be read with the following additions: (1) Sl. No. 2 shall be added in Table ‘B’ as below: Sl. No. Name of Manufacturer Product/ Brand Name (1) (2) (3) 2. M/s Jedux Parenteral Private Limited JEDUX DOUBLE PORT WITH EURO HEAD, JPORT PLUS [PN/260/128/2024/F /F. No. 8(128)/2024/D.P./NPPA-Div.-II] MAHAVEER SAINI, Dy. Director पररजिष्ट नई दिल्ली, 19 दिसम्बर, 2024 का.आ. 5503(अ).—भारत के असाधारण रािपत्र म ें प्रकाजित राष्ट्रीय औषध मल्ू य जनधारव ण प्राजधकरण के आििे संख्या 1555(अ) दिनांक 26 मार् व 2024 के साथ परित 2291(अ) दिनांक 14 िून 2024, िो उसमें जनर्िवष्ट अनुसूजर्त फॉमूवलेिन के अजधकतम मल्ू य जनधावरण से संबंजधत ह,ै को अब से जनम्नजलजखत िोडकर पढा िाना र्ाजहए:[भाग II—खण् ड 3(ii)] भारत का रािपत्र : असाधारण 5 (1) क्र. संख्या 9 को ताजलका 'बी' में जनम्नानुसार िोडा िाएगा: क्र.स ं जर्जनमातव ाओं का नाम उत्पाि/ब्ाडं का नाम (1) (2) (3) 9. मेससव िेडुक्स परेंटल्स प्राइर्ेट जलजमटेड िेडुक्स डबल पोटव यूरो हडे कैप के साथ, िपे ोटव प्लस [पी.एन./260/128/2024/एफ /फा. स.ं 8(128)/2024/डी.पी./एनपीपीए-डीर्ी-II] महार्ीर सैनी, उप जनिेिक ADDENDUM New Delhi, the 19th December, 2024 S.O. 5503(E).—The National Pharmaceutical Pricing Authority’s Order No. 1555(E) dated 26th March 2024 read with S.O. 2291(E) dated 14th June 2024, published in the Gazette of India, Extraordinary, related to ceiling price fixation of the scheduled formulation as specified therein is henceforth to be read with the following additions: (1) Sl. No. 9 shall be added in Table ‘B’ as below: Sl. No. Name of Manufacturer Product/Brand Name (1) (2) (3) 9. M/s Jedux Parenteral Private Limited JEDUX DOUBLE PORT WITH EURO HEAD, JPORT PLUS [PN/260/128/2024/F /F. No. 8(128)/2024/D.P./NPPA-Div.-II] MAHAVEER SAINI, Dy. Director पररजिष्ट नई दिल्ली, 19 दिसम्बर, 2024 का.आ. 5504(अ).—भारत के असाधारण रािपत्र म ें प्रकाजित राष्ट्रीय औषध मल्ू य जनधारव ण प्राजधकरण के आििे संख्या 1557(अ) दिनांक 26 मार् व 2024 के साथ परित 2287(अ) दिनांक 14 िून 2024 , िो उसमें जनर्िवष्ट अनुसूजर्त फॉमूवलेिन के अजधकतम मल्ू य जनधावरण से संबंजधत ह,ै को अब से जनम्नजलजखत िोडकर पढा िाना र्ाजहए: (1) क्र. संख्या 8 को ताजलका 'बी' में जनम्नानुसार िोडा िाएगा: क्र.स ं जर्जनमातव ाओं का नाम उत्पाि/ब्ाडं का नाम (1) (2) (3) 8. मेससव िेडुक्स परेंटल्स प्राइर्ेट जलजमटेड िेडुक्स डबल पोटव यूरो हडे कैप के साथ, िपे ोटव प्लस [पी.एन./260/128/2024/एफ /फा. स.ं 8(128)/2024/डी.पी./एनपीपीए-डीर्ी-II] महार्ीर सैनी, उप जनिेिक ADDENDUM New Delhi, the 19th December, 2024 S.O. 5504(E).—The National Pharmaceutical Pricing Authority’s Order No. 1557(E) dated 26th March 2024 read with S.O. 2287 (E) dated 14th June 2024, published in the Gazette of India, Extraordinary, related to ceiling price fixation of scheduled formulation as specified therein is henceforth to be read with the following additions: (1) Sl. No. 8 shall be added in Table ‘B’ as below:6 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] Sl. No. Name of Manufacturer Product/ Brand Name (1) (2) (3) 8. M/s Jedux Parenteral Private Limited JEDUX DOUBLE PORT WITH EURO HEAD, JPORT PLUS [PN/260/128/2024/F /F. No. 8(128)/2024/D.P./NPPA-Div.-II] MAHAVEER SAINI, Dy. Director पररजिष्ट नई दिल्ली, 19 दिसम्बर, 2024 का.आ. 5505(अ).—भारत के असाधारण रािपत्र म ें प्रकाजित राष्ट्रीय औषध मल्ू य जनधारव ण प्राजधकरण के आििे संख्या 2289(अ) दिनांक 14 िनू 2024, िो उसमें जनर्िष्टव अनसु ूजर्त फॉमूवलेिन के अजधकतम मूल्य जनधारव ण से संबंजधत ह,ै को अब से जनम्नजलजखत िोडकर पढा िाना र्ाजहए: (1) क्र. संख्या 2 को ताजलका 'बी' में जनम्नानुसार िोडा िाएगा: क्र.स ं जर्जनमातव ाओं का नाम उत्पाि/ब्ाडं का नाम (1) (2) (3) 2. मेससव िेडुक्स परेंटल्स प्राइर्ेट जलजमटेड िेडुक्स डबल पोटव यूरो हडे कैप के साथ, िपे ोटव प्लस [पी.एन./260/128/2024/एफ /फा. स.ं 8(128)/2024/डी.पी./एनपीपीए-डीर्ी-II] महार्ीर सैनी, उप जनिेिक ADDENDUM New Delhi, the 19th December, 2024 S.O. 5505(E).—The National Pharmaceutical Pricing Authority’s Order No 2289(E) dated 14th June 2024, published in the Gazette of India, Extraordinary, related to ceiling price fixation of scheduled formulation as specified therein is henceforth to be read with the following additions: (1) Sl. No. 2 shall be added in Table ‘B’ as below: Sl. No. Name of Manufacturer Product/ Brand Name (1) (2) (3) 2. M/s Jedux Parenteral Private Limited JEDUX DOUBLE PORT WITH EURO HEAD, JPORT PLUS [PN/260/128/2024/F /F. No. 8(128)/2024/D.P./NPPA-Div.-II] MAHAVEER SAINI, Dy. Director Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064 and Published by the Controller of Publications, Delhi-110054.

Continue your research

Related Documents from Ministry of Chemicals and Fertilizers